Published in Virchows Arch on October 19, 2014
Recent advances in the molecular diagnostics of gastric cancer. World J Gastroenterol (2015) 1.01
Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma. PLoS One (2016) 0.85
Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma. BMC Clin Pathol (2016) 0.77
SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB. Oncotarget (2017) 0.77
Expression of IFITM1 as a prognostic biomarker in resected gastric and esophageal adenocarcinoma. Biomark Res (2016) 0.76
Prognostic impact of tumour-associated B cells and plasma cells in oesophageal and gastric adenocarcinoma. J Gastrointest Oncol (2016) 0.75
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med (2006) 26.37
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32
Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med (2012) 15.43
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17
SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature (2008) 4.27
Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol (2001) 3.83
Recent patterns in gastric cancer: a global overview. Int J Cancer (2009) 3.75
A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell (1992) 3.46
SATB1 targets chromatin remodelling to regulate genes over long distances. Nature (2002) 3.10
SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Oncol Rep (2010) 1.56
Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol (2009) 1.53
Genome organizing function of SATB1 in tumor progression. Semin Cancer Biol (2012) 1.45
Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci (2013) 1.44
Correlation of SATB1 overexpression with the progression of human rectal cancer. Int J Colorectal Dis (2011) 1.40
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol (2012) 1.38
Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. APMIS (2010) 1.37
The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 1.36
Overexpression of SATB1 in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec (2010) 1.29
SATB1 gene expression and breast cancer prognosis. Breast (2010) 1.18
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. BMC Cancer (2012) 1.17
A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer. Br J Cancer (2012) 1.11
SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo. PLoS One (2013) 1.04
Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer. Oligonucleotides (2011) 1.00
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer. J Ovarian Res (2012) 0.98
High expression of RNA-binding motif protein 3 in esophageal and gastric adenocarcinoma correlates with intestinal metaplasia-associated tumours and independently predicts a reduced risk of recurrence and death. Biomark Res (2014) 0.95
Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer. Histopathology (2014) 0.95
The dichotomy in carcinogenesis of the distal esophagus and esophagogastric junction: intestinal-type vs cardiac-type mucosa-associated adenocarcinoma. Mod Pathol (2011) 0.93
Special AT-rich sequence-binding protein 1 promotes cell growth and metastasis in colorectal cancer. World J Gastroenterol (2013) 0.93
Re: The role of SATB1 in breast cancer pathogenesis. J Natl Cancer Inst (2010) 0.92
Special AT-rich sequence binding protein 1 regulates the multidrug resistance and invasion of human gastric cancer cells. Oncol Lett (2012) 0.92
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma. J Transl Med (2014) 0.91
International network of cancer genome projects. Nature (2010) 20.35
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov (2011) 7.65
A genecentric Human Protein Atlas for expression profiles based on antibodies. Mol Cell Proteomics (2008) 6.45
Recommendations from the 2008 International Summit on Proteomics Data Release and Sharing Policy: the Amsterdam principles. J Proteome Res (2009) 3.77
Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res (2011) 2.85
Toward a confocal subcellular atlas of the human proteome. Mol Cell Proteomics (2007) 2.80
Waterbirths compared with landbirths: an observational study of nine years. J Perinat Med (2004) 2.72
Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J Natl Cancer Inst (2006) 2.71
Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics (2013) 2.53
A global view of protein expression in human cells, tissues, and organs. Mol Syst Biol (2009) 2.41
Correlations between RNA and protein expression profiles in 23 human cell lines. BMC Genomics (2009) 2.36
The human proteome project: current state and future direction. Mol Cell Proteomics (2011) 2.34
Antibodypedia, a portal for sharing antibody and antigen validation data. Mol Cell Proteomics (2008) 2.34
The genome sequence of Mycoplasma mycoides subsp. mycoides SC type strain PG1T, the causative agent of contagious bovine pleuropneumonia (CBPP). Genome Res (2004) 2.33
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer (2012) 2.16
The biotin-streptavidin interaction can be reversibly broken using water at elevated temperatures. Electrophoresis (2005) 2.12
Immunofluorescence and fluorescent-protein tagging show high correlation for protein localization in mammalian cells. Nat Methods (2013) 2.05
A Populus EST resource for plant functional genomics. Proc Natl Acad Sci U S A (2004) 2.04
ProteomeBinders: planning a European resource of affinity reagents for analysis of the human proteome. Nat Methods (2007) 2.04
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice. J Clin Invest (2011) 1.96
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin Cancer Res (2006) 1.87
Prediction of the human membrane proteome. Proteomics (2010) 1.85
Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer. Am J Pathol (2009) 1.81
Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma. Blood (2007) 1.73
CXCR4 and cancer. Pathol Int (2010) 1.73
Isolation and characterization of progenitor-like cells from human renal proximal tubules. Am J Pathol (2011) 1.72
Homeodomain leucine zipper class I genes in Arabidopsis. Expression patterns and phylogenetic relationships. Plant Physiol (2005) 1.67
A non-functional retinoblastoma tumor suppressor (RB) pathway in premenopausal breast cancer is associated with resistance to tamoxifen. Cell Cycle (2011) 1.60
Ultrasound and early tape mobilization--a practical solution for treating postoperative voiding dysfunction. Neurourol Urodyn (2013) 1.60
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res (2008) 1.59
Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res (2010) 1.57
Anti-idiotypic protein domains selected from protein A-based affibody libraries. Proteins (2002) 1.52
Expression of the RNA-binding protein RBM3 is associated with a favourable prognosis and cisplatin sensitivity in epithelial ovarian cancer. J Transl Med (2010) 1.51
Two years of adjuvant tamoxifen in premenopausal patients with breast cancer: a randomised, controlled trial with long-term follow-up. Eur J Cancer (2005) 1.45
A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol Cell Proteomics (2007) 1.43
Classification of breast cancer using genetic algorithms and tissue microarrays. Clin Cancer Res (2006) 1.43
ERK phosphorylation is linked to VEGFR2 expression and Ets-2 phosphorylation in breast cancer and is associated with tamoxifen treatment resistance and small tumours with good prognosis. Oncogene (2005) 1.42
Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer. Diagn Pathol (2012) 1.38
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat (2013) 1.38
Nuclear expression of the RNA-binding protein RBM3 is associated with an improved clinical outcome in breast cancer. Mod Pathol (2009) 1.34
Expression of the cytoskeleton linker protein ezrin in human cancers. Clin Exp Metastasis (2007) 1.34
PKCalpha expression is a marker for breast cancer aggressiveness. Mol Cancer (2010) 1.34
The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. Mol Biol Cell (2007) 1.33
Expression and subcellular distribution of novel glomerulus-associated proteins dendrin, ehd3, sh2d4a, plekhh2, and 2310066E14Rik. J Am Soc Nephrol (2007) 1.33
Functional profiling reveals that only a small number of phytochrome-regulated early-response genes in Arabidopsis are necessary for optimal deetiolation. Plant Cell (2006) 1.31
Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer. Diagn Pathol (2013) 1.28
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 1.28
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol (2011) 1.27
Tape functionality: sonographic tape characteristics and outcome after TVT incontinence surgery. Neurourol Urodyn (2008) 1.27
Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study. Int J Cancer (2011) 1.22
Determination of binding specificities in highly multiplexed bead-based assays for antibody proteomics. Mol Cell Proteomics (2006) 1.22
Hypoxia inducible factor-1alpha is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response. Int J Cancer (2006) 1.20
A genome-wide survey of HD-Zip genes in rice and analysis of drought-responsive family members. Plant Mol Biol (2007) 1.20
Extensive linkage disequilibrium in small human populations in Eurasia. Am J Hum Genet (2002) 1.20
Glcci1 deficiency leads to proteinuria. J Am Soc Nephrol (2011) 1.19
Automated Analysis of Human Protein Atlas Immunofluorescence Images. Proc IEEE Int Symp Biomed Imaging (2009) 1.18
Epitope mapping of antibodies using bacterial surface display. Nat Methods (2008) 1.18
Detection and analysis of low-abundance cell-surface biomarkers using enzymatic amplification in microfluidic droplets. Angew Chem Int Ed Engl (2009) 1.17
CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer. Int J Cancer (2007) 1.17
Molecular profiling reveals low- and high-grade forms of primary melanoma. Clin Cancer Res (2012) 1.17
Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer. BMC Cancer (2012) 1.17
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer. BMC Cancer (2010) 1.17
RBM3-regulated genes promote DNA integrity and affect clinical outcome in epithelial ovarian cancer. Transl Oncol (2011) 1.16
Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues. Mol Cell Proteomics (2003) 1.15
Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmö Diet and Cancer Study. J Transl Med (2011) 1.15
Sun1 forms immobile macromolecular assemblies at the nuclear envelope. Biochim Biophys Acta (2008) 1.12
A community standard format for the representation of protein affinity reagents. Mol Cell Proteomics (2009) 1.11
Contribution of antibody-based protein profiling to the human Chromosome-centric Proteome Project (C-HPP). J Proteome Res (2012) 1.11
Forkhead box F1 regulates tumor-promoting properties of cancer-associated fibroblasts in lung cancer. Cancer Res (2010) 1.11
High nuclear RBM3 expression is associated with an improved prognosis in colorectal cancer. Proteomics Clin Appl (2011) 1.10
Gender, anthropometric factors and risk of colorectal cancer with particular reference to tumour location and TNM stage: a cohort study. Biol Sex Differ (2012) 1.09
Antibody suspension bead arrays within serum proteomics. J Proteome Res (2008) 1.08
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer. Breast Cancer Res (2008) 1.08
Tape functionality: position, change in shape, and outcome after TVT procedure--mid-term results. Int Urogynecol J (2010) 1.07